Saturday, October 16, 2021

SARS-CoV-2 virus

Telangana keeps Covid in check

State’s response unique and strategic, say health officials

Oravax inks pact with Premas Biotech for injectable vaccine technology

Indian partner plans to manufacture, test and commercialise the injectable vaccine in the country where the Covid-19 vaccine market is expected to grow to over $2.3 billion by 2027

IIT-Hyderabad develops country’s first rapid electronic Covid RNA test kit

The test kit can produce results within 30 minutes for both symptomatic and asymptomatic patients.

Booster shots of Covid vaccine essential, say experts

According to senior doctors in Hyderabad, at some point in the near future, as the protection provided by Covid vaccines wane, there will be demand for booster shots

Covid fight not over yet, warn experts

Public health officials warn public not to get complacent and allow virus to regain foothold

Covid can activate dormant bacterial infection, TB: Study

The study, led by researchers from the Indian Institute of Technology, Guwahati, and University of Massachusetts, showed that infection with a specific coronavirus strain reactivated dormant Mycobacterium tuberculosis (MTB) in mice.

Editorial: The deadly ‘Delta’ variant

Vaccination rate must go up 3-fold to cover 80% of adult population by Sept, given the rapid mutation of the virus

Researchers at China’s Wuhan bio lab sought hospital care before COVID-19 outbreak

The origins of the COVID-19 remain a widely debated topic, with some scientists and politicians maintaining that the possibility of a lab leak of the deadly virus exists.

COVID-19: DRDO develops antibody detection kit DIPCOVAN

It was developed indigenously by scientists, followed by extensive validation on over 1000 patient samples at various COVID hospitals in Delhi.

New rapid antigen test can detect Covid in saliva accurately

A team of scientists from Hokkaido University in Japan used a novel antigen-based kit, Lumipulse SARS-CoV-2 Ag kit (Lumipulse), developed by a Japanese company Fujirebio

WHO declares Indian Covid variant ‘of concern’

The B1617 variant was, till now, deemed a 'variant of interest' by the WHO.

VINS Bioproducts to begin phase I clinical trial for Vincov-19

Covid-19 drug candidate has been developed by VINS Bioproducts in collaboration with Centre for Cellular and Molecular Biology and University of Hyderabad

N440K variant of Coronavirus dominant in Telangana, AP

Double mutant strains found in 4-5% of samples in Telangana

This is how highly infectious Covid variant gets neutralised

Large-scale supercomputer simulations at the atomic level showed that the dominant "G form" variant of the Covid-19 causing virus is more infectious partly.

Second Covid wave far more intense in Telangana

The trend could be an indication that the community and healthcare infrastructure in Telangana might be under stress for a prolonged period due to new Covid infections

Latest News

- Advertisement -